Study suggests new approach to fighting malaria reduces severe illness and deaths in kids


Researchers conducting a malaria trial in Burkina Faso and Mali found that when children received both seasonal vaccinations and antimalarial drugs, rather than just one intervention, there was a 70 percent drop in hospitalizations and deaths related to the disease, The Guardian reports.
Their study was published Wednesday in The New England Journal of Medicine. Malaria is a mosquito-borne disease, and in 2019, 94 percent of cases and deaths were reported in Africa. The most vulnerable group is children 5 and under — in 2019, they accounted for 67 percent of malaria deaths worldwide, the World Health Organization said.
The trial, led by a team from the London School of Hygiene and Tropical Medicine, followed 6,000 children between five and 17 months living in Burkina Faso and Mali. The study lasted three years, with the children receiving a malaria vaccine known as RTS,S and four courses of antimalarial medications annually during the time of highest transmission: the rainy season. Researchers found that this combination of a vaccine and antimalarial drugs, compared to just the vaccine, reduced hospitalizations by 70.5 percent and death by 72.9 percent.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Daniel Chandramohan, the study's co-lead author, told The Guardian the results of the trial "were much more successful than we had anticipated. Our work has shown a combination approach using a malarial vaccine seasonally — similar to how countries use influenza vaccine — has the potential to save millions of young lives in the African Sahel. Importantly, we didn't observe any new concerning pattern of side effects."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Kurdish PKK militia to disband for Turkey talks
speed read The Kurdistan Workers' Party will disarm after four decades of armed conflict with Turkey, putting an end to 'one of the longest insurgencies in the Middle East'
-
US, China agree to lower tariffs for 90 days
speed read US tariffs will fall to 30% from 145%, while China will cut its tax on US imports to 10% from 125%
-
India strikes Pakistan as tensions mount in Kashmir
speed read Pakistan's Prime Minister Shehbaz Sharif called it an 'act of war'
-
Israel approves plan to take over Gaza indefinitely
speed read Benjamin Netanyahu says the country is 'on the eve of a forceful entry'
-
Putin talks nukes as Kyiv slated for US air defenses
speed read 'I hope they will not be required,' Putin said of nuclear weapons on Russian state TV
-
US, Ukraine sign joint minerals deal
speed read The Trump administration signed a deal with Ukraine giving the US access to its mineral wealth
-
What happens if tensions between India and Pakistan boil over?
TODAY'S BIG QUESTION As the two nuclear-armed neighbors rattle their sabers in the wake of a terrorist attack on the contested Kashmir region, experts worry that the worst might be yet to come
-
Israel launches air strike on Beirut suburbs
Speed Read The attack targeting Hezbollah was Israel's third on the Lebanese capital since November's ceasefire